Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.

Kazem Anvari,Mehri Shahabadi,James S Welsh,Seyed Alireza Javadinia,Elham Zarei

Asian Pacific journal of cancer prevention : APJCP（2023）

引用 0|浏览1

暂无评分

摘要

The PFS is similar after the second line treatment of recurrent primary central nervous system malignancies either by re-irradiation or bevacizumab-based chemotherapy.

查看译文

关键词

second line treatment,chemotherapy,re-irradiation,bevacizumab-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要